We recently reported spatial methylation variability in IDH-mutant gliomas where we identified a high number of differentially methylated positions (DMPs) within the tumors as well as heterogeneous chromosomal copy number alterations (CNAs), with potential clinical implications in diagnostics [11]. This evidence concerns the gene IDH2 and central nervous system cancer.